Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 36,421 | 63,074 | 39,699 | 22,488 | 18,696 |
| Operating Income | -36,421 | -63,074 | -39,699 | -22,488 | -18,696 |
| Interest Expense | 1,904 | 604 | 147 | 114 | 106 |
| Other Income | 292 | 1,541 | 953 | 261 | 102 |
| Pre-tax Income | -38,033 | -62,137 | -38,893 | -22,341 | -18,700 |
| Income Tax | -479 | -1,310 | N/A | N/A | N/A |
| Net Income Continuous | -37,554 | -60,827 | -38,893 | -22,341 | -18,700 |
| Net Income | $-37,554 | $-60,827 | $-38,893 | $-22,341 | $-18,700 |
| EPS Basic Total Ops | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 |
| EPS Basic Continuous Ops | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 |
| EPS Diluted Total Ops | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 |
| EPS Diluted Continuous Ops | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 |
| EPS Diluted Before Non-Recurring Items | -1.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-35,890 | $-63,313 | $-39,806 | $-22,301 | $-18,367 |